A Korean multi-center, real-world, retrospective study of first-line pazopanib in unselected patients with metastatic renal clear-cell carcinoma

Lignende værker

• A Korean single-center, real-world, retrospective study of first-line weekly paclitaxel in patients with metastatic angiosarcoma
  af: Byeon, Seonggyu, et al.
  Udgivet: (2016)
• Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib
  af: Kim, Myung Soo, et al.
  Udgivet: (2018)
• Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study
  af: Jung, Ki Sun, et al.
  Udgivet: (2018)
• Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?
  af: Bonadioa, Renata Colombo, et al.
  Udgivet: (2019)
• Successful use of pazopanib for treatment of refractory metastatic hemangiopericytoma
  af: Lee, Su Jin, et al.
  Udgivet: (2014)